Pfizer Inc. closed 28.57% short of its 52-week high of $31.54, which the company reached on July 30th.

Cantor Fitzgerald analyst Carter Gould initiated coverage of Pfizer (PFE) with a Neutral rating and $24 price target Pfizer made “concrete ...